One paper reported that miR-27a upregulated in lung cancer cell lines and patients and impaired TGF-β signaling by inhibiting Smad2 and Smad4, and its overexpression decreased Smad2 and Smad4 mRNA and protein levels. This evidence concerns the gene SMAD4 and lung carcinoma.